At AccessDx, we are passionate about enhancing and extending patients’ lives by optimizing patient therapy. We believe we are genuinely making an impact on patient's lives - people who are precious to their friends and family. AccessDx is at the forefront of precision medicine. We are constantly seeking ways to live up to our vision: to make healthcare safer and more effective for every patient through personalized medicine at a cost that can be afforded by society and individuals. We provide clinical insights that improve patient outcomes. Only AccessDx has the integrated genomic solutions that provide physicians with the actionable intelligence they need to make more informed therapy decisions. AccessDx redefines the patient journey by combining diagnostics such as pharmacogenomics and therapeutic drug monitoring into proprietary solutions. From tumor diagnosis to treatment, AccessDx delivers the clinical insight physicians need while continuing to advance the field with data intelligence. AccessDx is currently licensed to run tests in all 50 states including New York, California, and other U.S. territories such as Puerto Rico. The company was founded in 2016 and is headquartered in Houston, TX.